CD1: From Molecules to Diseases
- PMID:29152228
- PMCID: PMC5664979
- DOI: 10.12688/f1000research.12178.1
CD1: From Molecules to Diseases
Abstract
The human cluster of differentiation (CD)1 system for antigen display is comprised of four types of antigen-presenting molecules, each with a distinct functional niche: CD1a, CD1b, CD1c, and CD1d. Whereas CD1 proteins were thought solely to influence T-cell responses through display of amphipathic lipids, recent studies emphasize the role of direct contacts between the T-cell receptor and CD1 itself. Moving from molecules to diseases, new research approaches emphasize human CD1-transgenic mouse models and the study of human polyclonal T cellsin vivo orex vivo in disease states. Whereas the high genetic diversity of major histocompatibility complex (MHC)-encoded antigen-presenting molecules provides a major hurdle for designing antigens that activate T cells in all humans, the simple population genetics of the CD1 system offers the prospect of discovering or designing broadly acting immunomodulatory agents.
Keywords: CD1; T cell receptor; TCR; antigen display.
Conflict of interest statement
Competing interests: The authors declare that they have no competing interests.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.
Figures


Similar articles
- Donor-unrestricted T cells in the human CD1 system.Huang S, Moody DB.Huang S, et al.Immunogenetics. 2016 Aug;68(8):577-96. doi: 10.1007/s00251-016-0942-x. Epub 2016 Aug 9.Immunogenetics. 2016.PMID:27502318Free PMC article.Review.
- CD1 antigen presentation and infectious disease.Dascher CC, Brenner MB.Dascher CC, et al.Contrib Microbiol. 2003;10:164-82. doi: 10.1159/000068136.Contrib Microbiol. 2003.PMID:12530326Review.
- CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.Roura-Mir C, Catálfamo M, Cheng TY, Marqusee E, Besra GS, Jaraquemada D, Moody DB.Roura-Mir C, et al.J Immunol. 2005 Mar 15;174(6):3773-80. doi: 10.4049/jimmunol.174.6.3773.J Immunol. 2005.PMID:15749918
- The versatility of the CD1 lipid antigen presentation pathway.Chancellor A, Gadola SD, Mansour S.Chancellor A, et al.Immunology. 2018 Jun;154(2):196-203. doi: 10.1111/imm.12912. Epub 2018 Mar 24.Immunology. 2018.PMID:29460282Free PMC article.Review.
- Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.Niazi KR, Ochoa MT, Sieling PA, Rooke NE, Peter AK, Mollahan P, Dickey M, Rabizadeh S, Rea TH, Modlin RL.Niazi KR, et al.Immunology. 2007 Dec;122(4):522-31. doi: 10.1111/j.1365-2567.2007.02666.x. Epub 2007 Jul 16.Immunology. 2007.PMID:17635609Free PMC article.
Cited by
- Editorial: Mycobacterial Glycolipids-Role in Immunomodulation and Targets for Vaccine Development.Källenius G, Nigou J, Cooper A, Correia-Neves M.Källenius G, et al.Front Immunol. 2020 Oct 8;11:603900. doi: 10.3389/fimmu.2020.603900. eCollection 2020.Front Immunol. 2020.PMID:33133110Free PMC article.No abstract available.
- Evolutionary Underpinnings of Innate-Like T Cell Interactions with Cancer.Banach M, Robert J.Banach M, et al.Immunol Invest. 2019 Oct;48(7):737-758. doi: 10.1080/08820139.2019.1631341. Epub 2019 Jun 21.Immunol Invest. 2019.PMID:31223047Free PMC article.Review.
- Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection.Win TS, Crisler WJ, Dyring-Andersen B, Lopdrup R, Teague JE, Zhan Q, Barrera V, Ho Sui S, Tasigiorgos S, Murakami N, Chandraker A, Tullius SG, Pomahac B, Riella LV, Clark RA.Win TS, et al.J Clin Invest. 2021 Apr 15;131(8):e135166. doi: 10.1172/JCI135166.J Clin Invest. 2021.PMID:33667197Free PMC article.Clinical Trial.
- Role of MHC class I pathways inMycobacterium tuberculosis antigen presentation.Witt KD.Witt KD.Front Cell Infect Microbiol. 2023 Mar 15;13:1107884. doi: 10.3389/fcimb.2023.1107884. eCollection 2023.Front Cell Infect Microbiol. 2023.PMID:37009503Free PMC article.Review.
- IdentifyingCD1c as a potential biomarker by the comprehensive exploration of tumor mutational burden and immune infiltration in diffuse large B cell lymphoma.Xiang X, Gao LM, Zhang Y, Zhu Q, Zhao S, Liu W, Ye Y, Tang Y, Zhang W.Xiang X, et al.PeerJ. 2023 Dec 11;11:e16618. doi: 10.7717/peerj.16618. eCollection 2023.PeerJ. 2023.PMID:38099311Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials